Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
The effects of tetrahydrobiopterin (BH4) treatment on brain function in individuals with phenylketonuria.
[phenylketonuria]
Phenylketonuria
(
PKU
)
is
a
rare
genetic
condition
characterized
by
an
absence
or
mutation
of
the
PAH
enzyme
,
which
is
necessary
for
the
metabolism
of
the
amino
acid
phenylalanine
into
tyrosine
.
Recently
,
sapropterin
dihydrochloride
,
a
synthetic
form
of
tetrahydrobiopterin
(
BH
4
)
,
has
been
introduced
as
a
supplemental
treatment
to
dietary
phe
control
for
PKU
.
Very
little
is
known
regarding
BH
4
treatment
and
its
effect
on
brain
and
cognition
.
The
present
study
represents
the
first
examination
of
potential
changes
in
neural
activation
in
patients
with
PKU
during
BH
4
treatment
.
To
this
end
,
we
utilized
an
n-back
working
memory
task
in
conjunction
with
functional
magnetic
resonance
imaging
(
fMRI
)
to
evaluate
functional
brain
integrity
in
a
sample
of
individuals
with
PKU
at
three
timepoints
:
Just
prior
to
BH
4
treatment
,
after
4
Â
weeks
of
treatment
,
and
after
6
Â
months
of
treatment
.
Neural
activation
patterns
observed
for
the
PKU
treatment
group
were
compared
with
those
of
a
demographically-matched
sample
of
healthy
non-
PKU
individuals
who
were
assessed
at
identical
time
intervals
.
Consistent
with
past
research
,
baseline
evaluation
revealed
impaired
working
memory
and
atypical
brain
activation
in
the
PKU
group
as
compared
to
the
non-
PKU
group
.
Most
importantly
,
BH
4
treatment
was
associated
with
improvements
in
both
working
memory
and
brain
activation
,
with
neural
changes
evident
earlier
(
4
-
week
timepoint
)
than
changes
in
working
memory
performance
(
6
-
month
timepoint
)
.
Diseases
Validation
Diseases presenting
"which is necessary for the metabolism of the amino acid phenylalanine into tyrosine"
symptom
phenylketonuria
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom
